首页> 美国卫生研究院文献>Microorganisms >Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid)
【2h】

Prevention of New Respiratory Episodes in Children with Recurrent Respiratory Infections: An Expert Consensus Statement from the World Association of Infectious Diseases and Immunological Disorders (WAidid)

机译:预防复发性呼吸道感染儿童的新呼吸道发作:来自世界传染病和免疫疾病联系的专家共识声明(WAIDID)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In healthy infants and young children, the development of respiratory tract infections (RTIs) is extremely common. In this paper, we present an international consensus of the available approaches for the prevention of recurrent RTIs in children, including the atopic/allergic ones as well as those with asthma. Few convincing measures for reducing the frequency and clinical relevance of recurrent respiratory episodes in RTI-prone children have been developed until now. Among the most recently suggested measures, immunotherapy is attractive, but only for OM-85 is there a sufficient number of well-conducted clinical trials confirming efficacy in RTIs prevention with an adequate safety profile. In the case of probiotics, it is not clear which bacteria can offer the best results and which dosage and schedule of administration are the most effective. The problems of dosage and the schedule of administration are not solved also for vitamin D, despite some promising efficacy results. While we wait for new knowledge, the elimination or reduction as much as possible of the environmental factors that favor RTIs, vaccination when available and/or indicated, and the systematic application of the traditional methods for infection prevention, such as hand washing, remain the best measures to prevent recurrent infections in RTI-prone children.
机译:在健康的婴儿和幼儿中,呼吸道感染(RTIS)的发展是非常常见的。在本文中,我们刊发了预防儿童复发性RTIS的可用方法的国际共识,包括特应性/过敏性和哮喘。在现在,已经开发出几乎没有令人信服的降低反复呼吸道发作的频率和临床相关性的措施。在最近建议的措施中,免疫疗法是有吸引力的,但仅针对OM-85有足够数量的良好进行的临床试验,证实在RTIS预防方面具有足够的安全性。在益生菌的情况下,尚不清楚哪种细菌可以提供最佳结果,并且其给药的剂量和时间表是最有效的。尽管有一些有前途的疗效结果,但对于维生素D也没有解决剂量和给药时间表。虽然我们等待新的知识,尽可能多地消除或减少,这些因素最有利于RTI,当可用和/或指出时的疫苗接种,以及传统的感染方法的系统应用,如洗手,仍然是防止反复感染在RTI-Prony儿童中的最佳措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号